CCER1: A Drug Target / Disease Biomarker (G196477)
CCER1: A Drug Target / Disease Biomarker
CCER1, short for cancer cell adhesion receptor 1, is a protein that is expressed in various tissues of the body, including the skin, hair, and nails. It is a member of the integrin receptor family, which is a large superfamily of transmembrane proteins that play a critical role in cell-cell and cell-extracellular matrix interactions.
One of the main functions of CCER1 is its role in cell adhesion. This protein helps to promote the stickiness of cells to one another by interacting with adhesion molecules on the cell surface. These interactions can be important for the formation of tissues and organs, as well as for the development and maintenance of various diseases.
Research has also suggested that CCER1 may have potential as a drug target. By interacting with specific molecules on the surface of cancer cells, CCER1 may be able to inhibit the growth and spread of these cells. This could make it an attractive target for cancer therapies that focus on targeting the delivery of drugs to tumors.
Another potential use for CCER1 is as a biomarker for various diseases. Its expression has been observed in a variety of tissues and conditions, including cancer, autoimmune diseases, and wound healing. This suggests that CCER1 may be a useful indicator of disease status and response to therapeutic treatment.
In addition to its potential drug-targeting and biomarkering applications, CCER1 is also of interest to researchers due to its unique structure and biology. As a member of the integrin receptor family, CCER1 has a unique mechanism of cell adhesion that is distinct from other proteins that bind to adhesion molecules. This unique feature may provide insight into the broader biology of cell adhesion and the mechanisms that regulate it.
Overall, CCER1 is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its role and its potential applications in medicine.
Protein Name: Coiled-coil Glutamate Rich Protein 1
The "CCER1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCER1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
CCER2 | CCHCR1 | CCIN | CCK | CCK receptor | CCKAR | CCKBR | CCL1 | CCL11 | CCL13 | CCL14 | CCL15 | CCL15-CCL14 | CCL16 | CCL17 | CCL18 | CCL19 | CCL2 | CCL20 | CCL21 | CCL22 | CCL23 | CCL24 | CCL25 | CCL26 | CCL27 | CCL28 | CCL3 | CCL3-AS1 | CCL3L1 | CCL3L3 | CCL3P1 | CCL4 | CCL4L1 | CCL4L2 | CCL5 | CCL7 | CCL8 | CCM2 | CCM2L | CCN1 | CCN2 | CCN3 | CCN4 | CCN5 | CCN6 | CCNA1 | CCNA2 | CCNB1 | CCNB1IP1 | CCNB2 | CCNB2P1 | CCNB3 | CCNC | CCND1 | CCND2 | CCND2-AS1 | CCND3 | CCNDBP1 | CCNE1 | CCNE2 | CCNF | CCNG1 | CCNG2 | CCNH | CCNI | CCNI2 | CCNJ | CCNJL | CCNK | CCNL1 | CCNL2 | CCNO | CCNP | CCNQ | CCNQP1 | CCNT1 | CCNT2 | CCNT2-AS1 | CCNT2P1 | CCNY | CCNYL1 | CCNYL2 | CCP110 | CCPG1 | CCR1 | CCR10 | CCR12P | CCR2 | CCR3 | CCR4 | CCR4-NOT transcription complex | CCR5 | CCR5AS | CCR6 | CCR7 | CCR8 | CCR9 | CCRL2 | CCS
